<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7917514" created="02/05/2006" creator="Hitomi MASUDA"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7917514</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Role of <term id="T1" lex="HIV-1_Nef" sem="Protein_molecule"><term id="T2" lex="HIV-1" sem="Virus">HIV-1</term> Nef</term> expression in <term id="T3" lex="activation_pathway" sem="Other">activation pathways</term> in <term id="A101" sem="Cell_natural"><term id="T4" lex="CD4" sem="Protein_molecule">CD4</term>+ T cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T1"/>
<clue>Role of HIV-1 Nef <clueType>expression</clueType> in activation pathways <clueLoc>in CD4+ T cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E101">
<type class="Physiological_process"/>
<theme idref="A101"/>
<clue>Role of HIV-1 Nef expression in <clueType>activation</clueType> pathways <linkTheme>in</linkTheme> CD4+ T cells.</clue>
</event>
<event KT="Investigation" id="E50">
<type class="Regulation"/>
<theme idref="E101"/>
<cause idref="E1"/>
<clue><clueType>Role</clueType> <linkCause>of</linkCause> HIV-1 Nef expression <linkTheme>in</linkTheme> activation pathways in CD4+ T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The role of the <term id="T5" lex="human_immunodeficiency_virus_(HIV-1)_Nef_protein" sem="Protein_molecule"><term id="T6" lex="human_immunodeficiency_virus" sem="Virus">human immunodeficiency virus</term> (<term id="T7" lex="HIV-1" sem="Virus">HIV-1</term>) <term id="T8" lex="Nef_protein" sem="Protein_molecule">Nef protein</term></term> in <term id="T9" lex="T_cell_activation_pathway" sem="Other"><term id="A48" sem="Cell_natural">T cell</term> <term id="T10" lex="activation_pathway" sem="Other">activation pathways</term></term> was investigated using a <term id="T11" lex="Jurkat_CD4+_cell_line" sem="Cell_cultured">Jurkat <term id="T12" lex="CD4" sem="Protein_molecule">CD4</term>+ cell line</term> stably transfected with a <term id="T13" lex="Nef_expression_vector" sem="Virus"><term id="A49" sem="Protein_molecule">Nef</term> expression vector</term>.</sentence>
<event KT="Method" id="E51">
<type class="Artificial_process"/>
<theme idref="A48"/>
<clue>The role of the human immunodeficiency virus (HIV-1) Nef protein in T cell <clueType>activation</clueType> pathways was investigated using a Jurkat CD4+ cell line stably transfected with a Nef expression vector.</clue>
</event>
<event KT="Investigation" id="E52" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E51"/>
<cause idref="T8"/>
<clue>The <clueType>role</clueType> <linkCause>of</linkCause> the human immunodeficiency virus (HIV-1) Nef protein <linkTheme>in</linkTheme> T cell activation pathways was <clueKT>investigated</clueKT> <clueExperiment>using a Jurkat CD4+ cell line stably transfected with a Nef expression vector</clueExperiment>.</clue>
</event>
<event KT="Method" id="E53">
<type class="Gene_expression"/>
<theme idref="A49"/>
<clue>The role of the human immunodeficiency virus (HIV-1) Nef protein in T cell activation pathways was investigated using a Jurkat CD4+ cell line stably transfected with a Nef <clueType>expression</clueType> <clueLoc>vector</clueLoc>.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E54">
<type class="Positive_regulation"/>
<theme idref="E53"/>
<clue>The role of the human immunodeficiency virus (HIV-1) Nef protein in T cell activation pathways was investigated using a <clueLoc>Jurkat CD4+ cell line</clueLoc> stably <clueType>transfected</clueType> with a Nef expression vector.</clue>
<comment>ARTIFICIAL</comment></event>
<sentence id="S3">Secretion of <term id="T14" lex="IL-2" sem="Protein_molecule">IL-2</term> and <term id="T15" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>, <term id="T16" lex="surface_expression" sem="Other">surface expression</term> of <term id="T17" lex="IL-2R" sem="Protein_molecule">IL-2R</term>, and <term id="A2" sem="DNA_domain_or_region">DNA</term>-binding activity of <term id="T18" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> and <term id="T19" lex="AP-1_(Fos/Jun)_complex" sem="Protein_complex">AP-1 (Fos/Jun) complex</term> in response to <term id="T20" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term>, <term id="T21" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>, or <term id="A1" sem="Protein_family_or_group">immobilized antibodies to <term id="T22" lex="CD3" sem="Protein_molecule">CD3</term></term> were monitored.</sentence>
<event KT="Other" id="E3">
<type class="Localization"/>
<theme idref="T14"/>
<clue><clueType>Secretion</clueType> <linkTheme>of</linkTheme> IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex in response to phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were monitored.</clue>
</event>
<event KT="Other" id="E4">
<type class="Localization"/>
<theme idref="T15"/>
<clue><clueType>Secretion</clueType> <linkTheme>of</linkTheme> IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex in response to phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were monitored.</clue>
</event>
<event KT="Investigation" id="E5" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T20"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E6" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T21"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E7" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="A1"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
<comment>TPS: A1</comment></event>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T20"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E100" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T21"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E201" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="A1"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T17"/>
<clue>Secretion of IL-2 and TNF-alpha, <clueLoc>surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex in response to phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were monitored.</clue>
</event>
<event KT="Investigation" id="E10" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T20"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E11" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T21"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E12" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="A1"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Other" id="E13">
<type class="Binding"/>
<theme idref="A2"/>
<theme idref="T18"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-<clueType>binding activity</clueType> <linkTheme>of</linkTheme> NF-kappa B and AP-1 (Fos/Jun) complex in response to phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were monitored.</clue>
</event>
<event KT="Other" id="E14">
<type class="Binding"/>
<theme idref="A2"/>
<theme idref="T19"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-<clueType>binding activity</clueType> <linkTheme>of</linkTheme> NF-kappa B and AP-1 (Fos/Jun) complex in response to phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were monitored.</clue>
</event>
<event KT="Investigation" id="E15" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="T20"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E16" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="T21"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E17" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="A1"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E18" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T20"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E19" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T21"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<event KT="Investigation" id="E20" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="A1"/>
<clue>Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (Fos/Jun) complex <linkTheme>in</linkTheme> <clueType>response</clueType> <linkCause>to</linkCause> phorbol myristate acetate, TNF-alpha, or immobilized antibodies to CD3 were <clueKT>monitored</clueKT>.</clue>
</event>
<sentence id="S4">These parameters were not modified by <term id="T23" lex="Nef_expression" sem="Other"><term id="T24" lex="Nef" sem="Protein_molecule">Nef</term> expression</term> in <term id="T25" lex="Jurkat_cell" sem="Cell_cultured">Jurkat cells</term>, whereas stimulation with the same stimuli resulted in partial inhibition of <term id="T26" lex="LTR_activation" sem="Other"><term id="T27" lex="LTR" sem="DNA_domain_or_region">LTR</term> activation</term> in <term id="T28" lex="Nef+_Jurkat_cell" sem="Cell_cultured"><term id="T29" lex="Nef" sem="Protein_molecule">Nef</term>+ <term id="T30" lex="Jurkat_cell" sem="Cell_cultured">Jurkat cells</term></term>.</sentence>
<event id="E21">
<type class="Gene_expression"/>
<theme idref="T24"/>
<clue>These parameters were not modified by Nef <clueType>expression</clueType> in Jurkat cells, whereas stimulation with the same stimuli resulted in partial inhibition of LTR activation in Nef+ Jurkat cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E22">
<type class="Regulation"/>
<theme idref="E3"/>
<cause idref="E21"/>
<clue><corefTheme>These parameters</corefTheme> were <cluePolarity>not</cluePolarity> <clueType>modified</clueType> <linkCause>by</linkCause> Nef expression <clueLoc>in Jurkat cells</clueLoc>, whereas stimulation with the same stimuli resulted in partial inhibition of LTR activation in Nef+ Jurkat cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E23">
<type class="Regulation"/>
<theme idref="E4"/>
<cause idref="E21"/>
<clue><corefTheme>These parameters</corefTheme> were <cluePolarity>not</cluePolarity> <clueType>modified</clueType> <linkCause>by</linkCause> Nef expression <clueLoc>in Jurkat cells</clueLoc>, whereas stimulation with the same stimuli resulted in partial inhibition of LTR activation in Nef+ Jurkat cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E24">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="E21"/>
<clue><corefTheme>These parameters</corefTheme> were <cluePolarity>not</cluePolarity> <clueType>modified</clueType> <linkCause>by</linkCause> Nef expression <clueLoc>in Jurkat cells</clueLoc>, whereas stimulation with the same stimuli resulted in partial inhibition of LTR activation in Nef+ Jurkat cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E25">
<type class="Regulation"/>
<theme idref="E13"/>
<cause idref="E21"/>
<clue><corefTheme>These parameters</corefTheme> were <cluePolarity>not</cluePolarity> <clueType>modified</clueType> <linkCause>by</linkCause> Nef expression <clueLoc>in Jurkat cells</clueLoc>, whereas stimulation with the same stimuli resulted in partial inhibition of LTR activation in Nef+ Jurkat cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E26">
<type class="Regulation"/>
<theme idref="E14"/>
<cause idref="E21"/>
<clue><corefTheme>These parameters</corefTheme> were <cluePolarity>not</cluePolarity> <clueType>modified</clueType> <linkCause>by</linkCause> Nef expression <clueLoc>in Jurkat cells</clueLoc>, whereas stimulation with the same stimuli resulted in partial inhibition of LTR activation in Nef+ Jurkat cells.</clue>
</event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="T27"/>
<clue>These parameters were not modified by Nef expression in Jurkat cells, whereas stimulation with the same stimuli resulted in partial inhibition of LTR <clueType>activation</clueType> in Nef+ Jurkat cells.</clue>
</event>
<event Manner="Low" id="E28">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<cause idref="T20"/>
<clue>These parameters were not modified by Nef expression in Jurkat cells, whereas stimulation with <corefCause>the same stimuli</corefCause> <linkCause>resulted in</linkCause> <clueManner>partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> LTR activation <clueLoc>in Nef+ Jurkat cells</clueLoc>.</clue>
</event>
<event Manner="Low" id="E29">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<cause idref="T21"/>
<clue>These parameters were not modified by Nef expression in Jurkat cells, whereas stimulation with <corefCause>the same stimuli</corefCause> <linkCause>resulted in</linkCause> <clueManner>partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> LTR activation <clueLoc>in Nef+ Jurkat cells</clueLoc>.</clue>
</event>
<event Manner="Low" id="E30">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<cause idref="A1"/>
<clue>These parameters were not modified by Nef expression in Jurkat cells, whereas stimulation with <corefCause>the same stimuli</corefCause> <linkCause>resulted in</linkCause> <clueManner>partial</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> LTR activation <clueLoc>in Nef+ Jurkat cells</clueLoc>.</clue>
</event>
<sentence id="S5">This inhibition was not mediated through <term id="T31" lex="Nef_phosphorylation" sem="Other"><term id="T32" lex="Nef" sem="Protein_molecule">Nef</term> phosphorylation</term> on <term id="T33" lex="Thr-15" sem="Amino_acid_monomer">Thr-15</term> or <term id="T34" lex="GTP-binding_activity" sem="Other"><term id="T35" lex="GTP" sem="Nucleotide">GTP</term>-binding activity</term> because <term id="T36" lex="mutation" sem="Other">mutations</term> in <term id="A3">critical sites</term> did not alter this inhibition.</sentence>
<event KT="Other" id="E31">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T32"/>
<clue>This inhibition was not mediated through Nef <clueType>phosphorylation</clueType> <clueLoc>on Thr-15</clueLoc> or GTP-binding activity because mutations in critical sites did not alter this inhibition.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E32">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="E31"/>
<clue><corefTheme>This inhibition</corefTheme> was <cluePolarity>not</cluePolarity> <clueType>mediated</clueType> <linkCause>through</linkCause> Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did not alter this inhibition.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E33">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="E31"/>
<clue><corefTheme>This inhibition</corefTheme> was <cluePolarity>not</cluePolarity> <clueType>mediated</clueType> <linkCause>through</linkCause> Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did not alter this inhibition.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E34">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="E31"/>
<clue><corefTheme>This inhibition</corefTheme> was <cluePolarity>not</cluePolarity> <clueType>mediated</clueType> <linkCause>through</linkCause> Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did not alter this inhibition.</clue>
</event>
<event KT="Other" id="E35">
<type class="Binding"/>
<theme idref="T32"/>
<theme idref="T35"/>
<clue>This inhibition was not mediated through Nef phosphorylation on Thr-15 or GTP-<clueType>binding activity</clueType> because mutations in critical sites did not alter this inhibition.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E36">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="E35"/>
<clue><corefTheme>This inhibition</corefTheme> was <cluePolarity>not</cluePolarity> <clueType>mediated</clueType> <linkCause>through</linkCause> Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did not alter this inhibition.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E37">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="E35"/>
<clue><corefTheme>This inhibition</corefTheme> was <cluePolarity>not</cluePolarity> <clueType>mediated</clueType> <linkCause>through</linkCause> Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did not alter this inhibition.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E38">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="E35"/>
<clue><corefTheme>This inhibition</corefTheme> was <cluePolarity>not</cluePolarity> <clueType>mediated</clueType> <linkCause>through</linkCause> Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did not alter this inhibition.</clue>
</event>
<event KT="Method" id="E39">
<type class="Mutagenesis"/>
<theme idref="A3"/>
<clue>This inhibition was not mediated through Nef phosphorylation on Thr-15 or GTP-binding activity because <clueType>mutations</clueType> <linkTheme>in</linkTheme> critical sites did not alter this inhibition.</clue>
<comment>ARTIFICIAL</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E40">
<type class="Regulation"/>
<theme idref="E28"/>
<cause idref="E39"/>
<clue>This inhibition was not mediated through Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did <cluePolarity>not</cluePolarity> <clueType>alter</clueType> <corefTheme>this inhibition</corefTheme>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E140">
<type class="Regulation"/>
<theme idref="E29"/>
<cause idref="E39"/>
<clue>This inhibition was not mediated through Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did <cluePolarity>not</cluePolarity> <clueType>alter</clueType> <corefTheme>this inhibition</corefTheme>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E240">
<type class="Regulation"/>
<theme idref="E30"/>
<cause idref="E39"/>
<clue>This inhibition was not mediated through Nef phosphorylation on Thr-15 or GTP-binding activity because mutations in critical sites did <cluePolarity>not</cluePolarity> <clueType>alter</clueType> <corefTheme>this inhibition</corefTheme>.</clue>
</event>
<sentence id="S6">Analysis of truncated <term id="T37" lex="LTR" sem="DNA_domain_or_region">LTRs</term> confirmed that inhibition of <term id="T38" lex="LTR_activation" sem="Other"><term id="T39" lex="LTR" sem="DNA_domain_or_region">LTR</term> activation</term> was not mediated through <term id="T40" lex="NF-kappa_B-binding_activity" sem="Other"><term id="T41" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>-binding activity</term> but through <term id="A4" sem="DNA_domain_or_region">the region containing the <term id="T42" lex="negative_responding_element" sem="DNA_family_or_group">negative responding elements</term></term> (<term id="T43" lex="NRE" sem="DNA_family_or_group">NREs</term>).</sentence>
<event KT="Other" id="E41">
<type class="Positive_regulation"/>
<theme idref="T39"/>
<clue>Analysis of truncated LTRs confirmed that inhibition of LTR <clueType>activation</clueType> was not mediated through NF-kappa B-binding activity but through the region containing the negative responding elements (NREs).</clue>
</event>
<event KT="Other" id="E42">
<type class="Negative_regulation"/>
<theme idref="E41"/>
<clue>Analysis of truncated LTRs confirmed that <clueType>inhibition</clueType> <linkTheme>of</linkTheme> LTR activation was not mediated through NF-kappa B-binding activity but through the region containing the negative responding elements (NREs).</clue>
</event>
<event KT="Other" id="E43">
<type class="Binding"/>
<theme idref="T41"/>
<clue>Analysis of truncated LTRs confirmed that inhibition of LTR activation was not mediated through NF-kappa B-<clueType>binding activity</clueType> but through the region containing the negative responding elements (NREs).</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E44">
<type class="Positive_regulation"/>
<theme idref="E42"/>
<cause idref="E43"/>
<clue>Analysis of truncated LTRs <clueKT>confirmed</clueKT> that inhibition of LTR activation was <cluePolarity>not</cluePolarity> <clueType>mediated</clueType> <linkCause>through</linkCause> NF-kappa B-binding activity but through the region containing the negative responding elements (NREs).</clue>
</event>
<event KT="Analysis" id="E45">
<type class="Positive_regulation"/>
<theme idref="E42"/>
<cause idref="A4"/>
<clue>Analysis of truncated LTRs <clueKT>confirmed</clueKT> that inhibition of LTR activation was not <clueType>mediated</clueType> through NF-kappa B-binding activity but <linkCause>through</linkCause> the region containing the negative responding elements (NREs).</clue>
<comment>TPS: A4</comment></event>
<sentence id="S7">These results suggest that <term id="T44" lex="Nef" sem="Protein_molecule">Nef</term> downmodulates <term id="T45" lex="LTR" sem="DNA_domain_or_region">LTR</term> activation without significantly inhibiting the capacity of <term id="T46" lex="T_cell" sem="Cell_natural">T cells</term> to respond to <term id="T47" lex="immunological_activation" sem="Other">immunological activations</term>.</sentence>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<clue>These results suggest that Nef downmodulates LTR <clueType>activation</clueType> without significantly inhibiting the capacity of T cells to respond to immunological activations.</clue>
</event>
<event CL="L2" KT="Analysis" id="E47">
<type class="Negative_regulation"/>
<theme idref="E46"/>
<cause idref="T44"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that Nef <clueType>downmodulates</clueType> LTR activation without significantly inhibiting the capacity of T cells to respond to immunological activations.</clue>
</event>
<event KT="Other" id="E48">
<type class="Physiological_process"/>
<theme idref="T46"/>
<cause idref="T47"/>
<clue>These results suggest that Nef downmodulates LTR activation without significantly inhibiting the capacity of T cells <linkTheme>to</linkTheme> <clueType>respond</clueType> <linkCause>to</linkCause> immunological activations.</clue>
</event>
<event KT="Other" Manner="High" Polarity="Negative" assertion="non-exist" id="E49">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="E47"/>
<clue>These results suggest that Nef downmodulates LTR activation <cluePolarity>without</cluePolarity> <clueManner>significantly</clueManner> <clueType>inhibiting</clueType> the capacity of T cells to respond to immunological activations.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
